Three Strategic Moves Position AbbVie for Future Growth

While broader markets posted gains in the latest session, AbbVie Inc. shares demonstrated a more measured performance. Behind this surface activity, however, the biopharmaceutical leader is executing a multi-faceted strategic play, sending a confident message to the investment community through decisive corporate actions.

Demonstrating its commitment to shareholder returns, AbbVie recently declared a quarterly dividend of $1.64 per share. This announcement extends a remarkable track record of consistent dividend increases maintained without interruption since the company’s inception in 2013. This unwavering dedication to returning capital has secured AbbVie?s prestigious standing among the S&P Dividend Aristocrats, a critical marker of reliability for investors with a long-term horizon.

Strategic Presence at a Premier Industry Conference

The Read more...